The Barda has launched its call for tender on Midazolam autoinjectors
Crossject is in a good position to compete
This could boost further Zeneo’s credibility and Crossject’s share price
18 Jun 2021
Another good piece of news for the group
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Another good piece of news for the group
- Published:
18 Jun 2021 -
Author:
Fabrice Farigoule -
Pages:
2
The Barda has launched its call for tender on Midazolam autoinjectors
Crossject is in a good position to compete
This could boost further Zeneo’s credibility and Crossject’s share price